（记者 王瀚黎） 每经头条（nbdtoutiao）——10倍价差刷屏！"外国人来华就医"火了，三位亲历者这样说⋯⋯ 每经AI快讯，创新医疗2月10日晚间发布公告称，公司第七届2026年第一次董事会临时会议于2026年2 月10日以通讯表决方式召开。会议审议了《关于为鸿润医药提供担保的议案》等文件。 ...

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：002173 证券简称：创新医疗 公告编号：2026-007 创新医疗管理股份有限公司 关于为鸿润医药提供担保的公告 一、本次担保情况概述 创新医疗管理股份有限公司（以下简称"公司"）全资控股子公司浙江鸿润 医药有限公司（以下简称"鸿润医药"）因生产经营需要，拟向北京银行股份有 限公司绍兴诸暨支行（以下简称"北京银行诸暨支行"）在人民币 1,000 万元的 授信额度内申请贷款，贷款期限为一年。公司于 2026 年 2 月 10 日召开的第七届 董事会 2026 年第一次临时会议审议通过了《关于为鸿润医药提供担保的议案》， 同意公司为鸿润医药在 1,000 万元授信额度内向北京银行诸暨支行申请贷款提 供担保。 本次担保总额为人民币 1,000 万元，未超过公司最近一期经审计净资产的 10%；本次董事会审议的担保议案生效后，公司担保总额为 5,320 万元，未超过 公司最近一期经审计净资产的 50%，也未超过公司最近一期经审计总资产的 30%； 最近一期鸿润医药资产负债率未超过 70%。根据《深圳证券交易所 ...

证券代码：002173 证券简称：创新医疗 公告编号：2026-006 创新医疗管理股份有限公司 第七届董事会 2026 年第一次临时会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 创新医疗管理股份有限公司（以下简称"公司"）第七届董事会于 2026 年 2 月 10 日召开了 2026 年第一次临时会议。本次会议以通讯表决方式召开。会议通 知于 2026 年 2 月 6 日以书面形式发出。本次会议由陈海军董事长主持，应出席 董事 9 名，实际出席 9 名。本次会议召开符合《公司法》及公司《章程》的规定， 合法有效。 二、董事会会议审议情况 与会董事就议案进行了审议、表决，以 9 票赞成、0 票反对、0 票弃权的表 决结果一致通过了《关于为鸿润医药提供担保的议案》。 为满足浙江鸿润医药有限公司生产经营需要，有利于保障其业务发展，公司 决定为浙江鸿润医药有限公司在1,000万元授信额度内向北京银行股份有限公司 绍兴诸暨支行申请贷款提供担保。 三、备查文件 公司《第七届董事会 2026 年第一次临时会议决议》。 特此公告。 创 ...

Group 1 - The core viewpoint of the article highlights the increasing investment and research activity in the brain-computer interface (BCI) industry in China, with a focus on key companies and patent trends [1][4][5] Group 2 - The research and development investment in the BCI industry by listed companies in China is steadily increasing from 2020 to 2024, indicating a strengthening of R&D efforts [1] - The number of patent applications in China's BCI industry showed a steady growth trend, peaking at 258 applications in 2021, followed by a decrease to 209 applications in 2024 [4] - Tianjin University is identified as the leading patent applicant in the BCI sector, with a total of 126 related patents, followed by South China University of Technology and Xi'an Jiaotong University with 80 and 78 patents respectively [5][7] - The most popular technology patents in the BCI industry are in the category of electrical digital data processing (G06F), with a total of 1,013 patents, followed by diagnostic and surgical technologies (A61B) with 712 patents, and specific computing models (G06N) with 313 patents [8]

Group 1: Innovation in Medical Technology - Innovation Medical (002173) has established itself in the medical service sector, focusing on brain-computer interface (BCI) technology for clinical applications, particularly in neuro-rehabilitation and cardiovascular treatment [1][20] - The company's BCI-4000 product is in Phase III clinical trials, utilizing invasive electrodes to collect brain signals for device control, aiding rehabilitation for high-level paraplegics [1][20] - With the implementation of insurance reimbursement policies for BCI, the clinical transition process is expected to accelerate, potentially leading to significant growth in the neuro-rehabilitation business [1][20] Group 2: Digital Entertainment and AI Integration - Talking Tom (300459) leverages its popular IPs in digital entertainment and is actively exploring the integration of AI with brain-computer interfaces to create immersive interactive experiences [2][21] - The core business includes IP operation, mobile app development, and digital content creation, focusing on leisure and children's education [2][21] - The company aims to develop brain-controlled games and immersive entertainment applications, enhancing user engagement and monetization capabilities [2][21] Group 3: Precision Components in Medical Devices - Meihua Medical (301363) specializes in manufacturing precision medical components, providing essential support to global medical device companies, and has recently entered the brain-computer interface supply chain [3][22] - The company produces components for cardiovascular and neuro-interventional devices, including precision structural parts for BCI equipment [3][22] - As demand for BCI devices increases, the company anticipates a steady growth in orders for precision components, enhancing collaboration with BCI firms [3][22] Group 4: AI and Brain-Computer Interface Algorithms - Yanshan Technology (002195) focuses on brain-like intelligence and AI, with a strong emphasis on developing neural signal decoding algorithms for brain-computer interfaces [4][23] - The company aims to optimize brain signal decoding efficiency through AI algorithms, enhancing the precision control capabilities of BCI devices [4][23] - As the demand for algorithm precision in BCI increases, the company expects growth in algorithm licensing and system integration services [4][23] Group 5: Network Solutions for Brain-Computer Interfaces - StarNet Ruijie (002396) is a leading provider of network equipment and solutions, exploring network support solutions for brain-computer interface applications [5][25] - The company offers high-speed data transmission and processing solutions for BCI devices, facilitating real-time brain signal transmission and cloud analysis [5][25] - With the rising demand for data transmission efficiency in BCI, the company anticipates continued growth in high-speed network equipment demand [5][25] Group 6: Pain Management and Neuroregulation - Aipeng Medical (300753) specializes in pain management and neuroregulation, exploring the application of brain-computer interfaces in postoperative pain relief and neuro-rehabilitation [6][26] - The company focuses on developing devices for pain management and neuroregulation, aiming to enhance treatment efficiency through brain-computer technology [6][26] - As the demand for neuro-rehabilitation grows, the application of BCI in medical settings is expected to accelerate [6][26] Group 7: Security and Identity Verification - Entropy Technology (301330) leverages biometric recognition and identity verification technologies, applying brain-computer interfaces in security and identity authentication [7][27] - The company provides solutions for financial, governmental, and transportation sectors, focusing on the development of BCI applications for secure interactions [7][27] - As the demand for precision and security in identity verification increases, the potential for BCI applications in security will gradually be realized [7][27] Group 8: Smart Control Components and IoT Solutions - Yingqu Technology (002925) specializes in smart control components and IoT solutions, providing essential support for brain-computer interface devices [8][28] - The company serves consumer electronics and smart home sectors, offering smart control components that facilitate intelligent interaction and data collection for BCI devices [8][28] - With the rising demand for intelligent BCI devices, the company expects a continuous increase in orders for smart control components [8][28] Group 9: Precious Metal Materials for BCI Electrodes - Guiyan Platinum (600459) focuses on the research and production of precious metal materials, providing critical materials for brain-computer interface electrodes [9][29] - The company supplies platinum-based alloy materials that enhance the biocompatibility and signal stability of BCI electrodes [9][29] - As the demand for mass production of BCI electrodes increases, the company anticipates a steady growth in orders for precious metal materials [9][29] Group 10: Automotive Applications of Brain-Computer Interfaces - Yachuang Electronics (301099) is exploring the application of brain-computer interfaces in smart driving, focusing on automotive-grade chips and power semiconductors [10][30] - The company aims to implement brain control technology for vehicle operation, opening new possibilities in automotive intelligence [10][30] - As the demand for human-machine interaction in smart driving increases, the potential for BCI applications in the automotive sector will gradually be realized [10][30] Group 11: Industrial Applications of Brain-Computer Interfaces - Zhongke Information (300678) focuses on intelligent monitoring and industrial detection, applying brain-computer interfaces in industrial settings [11][31] - The company aims to utilize brain signals for equipment status monitoring and fault prediction, enhancing industrial efficiency [11][31] - As the demand for monitoring precision in industrial automation increases, the application of BCI in industrial settings is expected to accelerate [11][31] Group 12: Third-Party Testing for BCI Compliance - Puni Testing (300887) is a leading third-party testing organization, providing compliance testing services for brain-computer interface devices [12][32] - The company offers testing for biocompatibility and electromagnetic compatibility, ensuring the safety and compliance of BCI products [12][32] - As the BCI industry matures, the demand for compliance testing services is expected to grow, supporting the healthy development of the industry [12][32] Group 13: Flexible Materials for BCI Devices - Pulit (002324) specializes in the research and production of polymer materials, providing essential flexible packaging materials for brain-computer interface devices [13][33] - The company enhances the durability and biocompatibility of BCI devices through its flexible packaging solutions [13][33] - As the demand for flexible materials in BCI devices increases, the company anticipates a steady growth in orders for packaging materials [13][33] Group 14: Intelligent Equipment and Robotics - Tianqi Co., Ltd. (002009) focuses on intelligent equipment manufacturing and industrial automation, exploring the application of brain-computer interfaces in industrial robotics [14][34] - The company aims to implement brain control technology for precise robotic operation, enhancing manufacturing efficiency [14][34] - As the demand for precision in industrial automation increases, the application of BCI in robotics is expected to accelerate [14][34] Group 15: Medical Rehabilitation and Training - Chengyitong (300430) specializes in pharmaceutical intelligent manufacturing and rehabilitation equipment, exploring the application of brain-computer interfaces in rehabilitation training [15][35] - The company focuses on optimizing rehabilitation plans through brain control technology, enhancing training efficiency [15][35] - As the demand for neuro-rehabilitation grows, the application of BCI in medical settings is expected to accelerate [15][35] Group 16: Military Communication and Navigation - Haige Communication (002465) is a core enterprise in military communication and navigation, providing specialized support for brain-computer interfaces [16][36] - The company offers military communication and data transmission solutions for BCI devices, enhancing interaction in specialized scenarios [16][36] - As the demand for BCI in military applications increases, the need for communication equipment is expected to grow [16][36] Group 17: Smart Terminals and Information Systems - Nanjing Panda (600775) leverages electronic manufacturing and communication technology, exploring the application of brain-computer interfaces in smart terminals [17][37] - The company aims to implement brain control technology for device operation, opening new possibilities in consumer electronics [17][37] - As the demand for interactive methods in smart terminals increases, the potential for BCI applications in consumer electronics will gradually be realized [17][37] Group 18: Biocompatible Coatings for BCI Devices - Taihe Technology (300801) specializes in fine chemicals and water treatment materials, providing essential biocompatible coating materials for brain-computer interface devices [18][38] - The company enhances the safety and durability of BCI devices through its biocompatible coatings [18][38] - As the demand for biocompatibility in BCI devices increases, the company anticipates a steady growth in orders for coating materials [18][38] Group 19: Cardiovascular and Neurointerventional Applications - Lepu Medical (300003) focuses on cardiovascular and neurointerventional fields, exploring the application of brain-computer interfaces in cardiac rehabilitation and neuroregulation [19][39] - The company aims to optimize treatment plans through brain control technology, enhancing rehabilitation efficiency [19][39] - As the demand for cardiovascular and neuro-rehabilitation grows, the application of BCI in medical settings is expected to accelerate [19][39] Group 20: Intelligent Nursing and Patient Monitoring - Yahua Electronics (301337) specializes in medical information systems and intelligent nursing devices, exploring the application of brain-computer interfaces in patient monitoring [20][40] - The company aims to utilize brain signals for real-time patient status monitoring, enhancing medical service efficiency [20][40] - As the demand for precise monitoring in medical services increases, the application of BCI in healthcare settings is expected to accelerate [20][40]

Core Insights - The AI healthcare sector experienced a rise of 1.31% on February 9, with Innovative Medical leading the gains [1] - The Shanghai Composite Index closed at 4123.09, up by 1.41%, while the Shenzhen Component Index closed at 14208.44, up by 2.17% [1] Market Flow - On the same day, the AI healthcare sector saw a net inflow of 587 million yuan from major funds, while retail investors experienced a net outflow of 105 million yuan [1] - The overall fund flow in the AI healthcare sector indicates a mixed sentiment, with major funds investing while retail investors withdrew [1]

该股主要指标及行业内排名如下： 创新医疗融资融券信息显示，融资方面，当日融资买入9138.35万元，融资偿还1.15亿元，融资净偿还 2325.24万元。融券方面，融券卖出0.0股，融券偿还0.0股，融券余量1.37万股，融券余额37.76万元。融 资融券余额5.42亿元。 近5日融资融券数据一览见下表： 证券之星消息，截至2026年2月6日收盘，创新医疗(002173)报收于27.56元，下跌6.1%，换手率 13.49%，成交量56.14万手，成交额15.58亿元。 2月6日的资金流向数据方面，主力资金净流出1.39亿元，占总成交额8.92%，游资资金净流入469.64万 元，占总成交额0.3%，散户资金净流入1.34亿元，占总成交额8.62%。 近5日资金流向一览见下表： 创新医疗2025年三季报显示，前三季度公司主营收入5.97亿元，同比下降2.11%；归母净利润472.44万 元，同比上升116.97%；扣非净利润-2946.98万元，同比上升6.05%；其中2025年第三季度，公司单季度 主营收入1.96亿元，同比下降3.16%；单季度归母净利润1608.57万元，同比上升236.15%；单季度扣 ...

2月6日创新医疗（002173）收盘报27.56元，跌6.1%，当日成交5614.46万元。前10个交易日资金流向情 况：主力资金累计净流出3.71亿元，股价累计下跌7.76%；融资余额累计减少2343.86万元，融券余量累 计增加2000股。 截至2026年2月6日收盘，创新医疗(002173)报收于27.56元，下跌6.1%，换手率13.49%，成交量56.14万 手，成交额15.58亿元。 当日关注点 交易信息汇总 来自交易信息汇总：2月6日创新医疗（002173）收盘报27.56元，跌6.1%，主力资金当日净流出 1.39亿元。 来自交易信息汇总：前10个交易日主力资金累计净流出3.71亿元，股价累计下跌7.76%。 2月6日主力资金净流出1.39亿元；游资资金净流入469.64万元；散户资金净流入1.34亿元。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

证券之星消息，截至2026年2月5日收盘，创新医疗(002173)报收于29.35元，上涨0.82%，换手率 17.39%，成交量72.38万手，成交额21.02亿元。 2月5日的资金流向数据方面，主力资金净流出5376.28万元，占总成交额2.56%，游资资金净流入 2663.53万元，占总成交额1.27%，散户资金净流入2712.74万元，占总成交额1.29%。 近5日资金流向一览见下表： 该股主要指标及行业内排名如下： 创新医疗2025年三季报显示，前三季度公司主营收入5.97亿元，同比下降2.11%；归母净利润472.44万 元，同比上升116.97%；扣非净利润-2946.98万元，同比上升6.05%；其中2025年第三季度，公司单季度 主营收入1.96亿元，同比下降3.16%；单季度归母净利润1608.57万元，同比上升236.15%；单季度扣非 净利润-1658.58万元，同比下降12.36%；负债率17.84%，投资收益2950.55万元，财务费用60.55万元， 毛利率10.08%。创新医疗（002173）主营业务：提供医疗服务。 资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状 ...

Core Insights - The article highlights the significant growth in the approval of innovative medical devices in China, indicating a strong focus on innovation and regulatory support in the sector [1] Group 1: Approval Statistics - In 2025, a total of 76 innovative medical devices were approved for market entry, representing a year-on-year increase of 17%, with a cumulative total of 391 devices approved [1] - There were 25 medical devices that received priority approval for market entry, showing a remarkable year-on-year growth of 212.5%, leading to a cumulative total of 171 devices approved [1]